Chennai meenakshi multispeciality Hospital Limited has announced its unaudited financial results for the third quarter ended December 31, 2025, showing a net loss of ₹54.06 lakhs compared to ₹62.95 lakhs loss in the corresponding quarter of the previous fiscal year. Despite the continued losses, the company demonstrated revenue growth and improved operational metrics during the reporting period.

Financial Performance Overview

The hospital's financial performance for Q3 FY26 showed mixed results with revenue growth but persistent losses:

Nine-Month Performance Analysis

For the nine-month period ended December 31, 2025, the company showed significant improvement in loss reduction:

Expense Structure and Operational Metrics

The company's expense breakdown for Q3 FY26 revealed the following cost structure:

• Employee benefits expenses: ₹263.38 lakhs (26.52% of total expenses)
• Other expenses: ₹491.04 lakhs (49.43% of total expenses)
• Purchase of stock-in-trade: ₹188.41 lakhs (18.97% of total expenses)
• Depreciation and amortisation: ₹26.75 lakhs
• Finance costs: ₹22.13 lakhs

The company maintained its equity share capital at ₹746.89 lakhs with a face value of ₹10 per share throughout the reporting periods.

Board Approval and Compliance

The Board of Directors approved these unaudited financial results at their meeting held on February 11, 2026. The meeting commenced at 12:00 hours and concluded at 16:00 hours. The financial results were prepared in accordance with Indian Accounting Standard 34 'Interim Financial Reporting' and comply with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Auditor Review and Corporate Governance

The statutory auditors, Elias George & Co., Chartered Accountants, conducted a limited review of the financial results. The results were reviewed and recommended for adoption by the Audit Committee before Board approval. The company operates in a single business segment related to healthcare services and maintains its registered office at Luz Church Road, Mylapore, Chennai.

Chennai Meenakshi Multispeciality Hospital Limited has announced that its Board of Directors will convene on February 11, 2026, to review and approve the company's third quarter financial results for FY26. The meeting represents a key milestone in the hospital's quarterly reporting cycle as it prepares to disclose its financial performance for the period ended December 31, 2025.

Board Meeting Details

The board meeting has been scheduled with specific parameters to ensure compliance with regulatory requirements and proper governance protocols.

Regulatory Compliance and Trading Window Closure

The company has implemented strict measures to comply with SEBI regulations regarding insider trading. As part of these compliance requirements, a comprehensive trading window closure has been put in effect to prevent any potential misuse of unpublished price-sensitive information.

The trading window restrictions apply to multiple stakeholder categories and remain in effect for an extended period to ensure complete regulatory adherence.

Corporate Communication and Documentation

The formal notice was communicated to BSE Limited under reference number CMMH/BSE/2025-26/71, demonstrating the company's commitment to transparent and timely disclosure. The communication was signed by R. Gomathi, Chairman and Managing Director, and follows the company's previous correspondence regarding trading window closure dated December 31, 2025.

The announcement adheres to Regulation 29(1)(a) and Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, ensuring all stakeholders receive adequate notice of the upcoming financial results disclosure. This systematic approach to corporate governance reflects the hospital's dedication to maintaining high standards of regulatory compliance and shareholder communication.